In recent years, deep neural networks with advanced data learning capabilities have seen growing application in the medical field.
9,10 Deep neural networks are primarily used in color fundus photographs, OCT, optical coherence tomography angiography (OCTA), fundus fluorescein angiography (FFA), and other bio-optical imaging in optical bioimaging for retinal diseases.
11–15 Compared to the limited research on myopic macular lesions, current deep learning–based studies on macular lesions have primarily focused on the identification of age-related macular lesions.
16–19 Fang et al.
20 developed an artificial intelligence (AI)–based pathologic myopia detection system for ophthalmology residency training, achieving a diagnostic accuracy of 88.6% using deep learning algorithms. Li et al.
21 reviewed advancements in imaging technologies for pathologic myopia and highlighted the role of AI, particularly in multimodal imaging, where AI achieved an accuracy of 92.1%, supporting early disease identification and clinical diagnosis. Meng et al.
22 proposed an AI classification method combining visual function and fundus features to identify high myopia, achieving 89.7% accuracy on multicenter data sets and improving clinical classification precision. Tan et al.
23 applied deep learning algorithms to fundus photographs for myopia diagnosis and integrated blockchain technology to advance AI-driven medical research. Their algorithm achieved an area under the curve (AUC) of 91% across multiple data sets, demonstrating excellent performance and cross-platform adaptability. El-Den et al.
24 reviewed the application of AI in detecting age-related macular degeneration (AMD), with some AI models achieving a diagnostic accuracy of 91.2%. Aranha et al.
25 proposed a deep transfer learning method that achieved an identification accuracy of 88.5% when processing low-quality fundus images. Du et al.
26 introduced a probabilistic contrastive learning approach to address data imbalance, improving model accuracy to 87.9%. Vaghefi et al.
27 achieved a diagnostic accuracy of 89.3% for intermediate dry AMD through multimodal retinal image analysis.